Skip to main content

Cel-Sci Corporation (CVM)

NYSEAMERICAN: CVM · IEX Real-Time Price · USD
11.95 -0.29 (-2.37%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap514.19M
Revenue (ttm)28,580
Net Income (ttm)-34.05M
Shares Out41.02M
EPS (ttm)-0.89
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume362,884
Open12.11
Previous Close12.24
Day's Range11.75 - 12.24
52-Week Range7.08 - 40.91
Beta2.24
Analystsn/a
Price Target12.00 (+0.4%)
Est. Earnings DateDec 28, 2021

About CVM

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and ...

IndustryBiotechnology
IPO DateJan 1, 1987
CEOGeert Kersten
CountryUnited States
Stock ExchangeNYSEAMERICAN
Ticker SymbolCVM
Full Company Profile

Financial Performance

In 2020, CVM's revenue was $597,427, an increase of 11.51% compared to the previous year's $535,776. Losses were -$30.28 million, 36.8% more than in 2019.

Financial Statements

News

CEL-SCI Corporation Reports Third Quarter Fiscal 2021 Financial Results

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation reports third quarter fiscal 2021 financial results.

1 month ago - Business Wire

Why CEL-SCI Stock Soared Today

The company attempted to clarify "confusion" related to its recent late-stage clinical results.

2 months ago - The Motley Fool

CEL-SCI Corporation Issues Letter to Shareholders

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #HeadandNeckCancer--CEL-SCI Corporation issues letter to shareholders.

2 months ago - Business Wire

3 Biotechs to Avoid Like the Plague in July

Generally speaking, biotech is a pretty innovative industry -- with a few notable bad apples.

Other symbols:CYDYNWBO
2 months ago - The Motley Fool

Discussion of Results of CEL-SCI's Phase 3 Trial Is Now Available

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #HeadandNeckCancer--The discussion of the results of CEL-SCI's Phase 3 Trial is now available.

2 months ago - Business Wire

Why CEL-SCI Shares Are Getting Hammered Today

CEL-SCI Corporation (NASDAQ:CVM) shares are trading lower by 27% at $9.33 on continued downward momentum following data from a Phase 3 Study of Multkine showing a 14.1% 5-year survival benefit in groups...

2 months ago - Benzinga

CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021

2 months ago - Business Wire

Will All End Well for This Popular Reddit Biotech?

Everything went the wrong way for Cel-Sci.

2 months ago - The Motley Fool

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CEL-SCI Corporation - CVM

NEW YORK, June 29, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE: CVM).  Such investors are advised to cont...

2 months ago - PRNewsWire

CVM Stock: The Big Trial News That Has Cel-Sci Plunging Today

Today, the trial results reported by Cel-Sci missed the mark, and investors are pricing in additional risks with CVM stock. The post CVM Stock: The Big Trial News That Has Cel-Sci Plunging Today appeare...

2 months ago - InvestorPlace

CEL-SCI's Immunotherapy Achieves Survival Benefit Of 14% Exceeding Pre-Defined 10% In Head & Cancer Patients

CEL-SCI Corporation (NYSE: CVM) has announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell carcinoma of the head and neck (SCCHN). In th...

2 months ago - Benzinga

CEL-SCI's Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group R...

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--Multikine immunotherapy produces significant 14.1% 5-Year survival benefit in group receiving surgery plus radiotherapy in landmark Phase 3 Study.

2 months ago - Business Wire

CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI Corporation invites participants to pre-submit questions for Annual Shareholder Meeting.

3 months ago - Business Wire

CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces the closing of $31.7 million bought deal offering.

3 months ago - Business Wire

CEL-SCI Stock Drops After Raising $37.1M Via Secondary Equity Offering

CEL-SCI Corporation (NYSE: CVM) has increased the size of its previously announced capital raise offering to 1.4 million shares, up from 1 million shares, at $22.62 per share representing a 5% discount ...

3 months ago - Benzinga

CEL-SCI Increases Previously Announced Bought Deal to $31.7 Million

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI Increases Previously Announced Bought Deal to $31.7 Million.

3 months ago - Business Wire

CEL-SCI Announces Bought Deal Offering

VIENNA, Va.--(BUSINESS WIRE)-- #CVM--CEL-SCI Announces Bought Deal Offering

3 months ago - Business Wire

Can You Count on This Popular Reddit Cancer-Treatment Stock?

Big news is coming for CEL-SCI, and we don't know which way the stock will move.

3 months ago - The Motley Fool

CEL-SCI Corporation Reports Second Quarter Fiscal 2021 Financial Results

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation reports second quarter fiscal 2021 financial results.

4 months ago - Business Wire

7 Reddit Stocks With Upcoming Catalysts To Watch

Reddit stocks always make noise across social media platforms. But these investments have serious catalysts connected to them.

Other symbols:CTRMMROSPPIYCBD
5 months ago - InvestorPlace

CEL-SCI Corporation Reports First Quarter Fiscal 2021 Financial Results

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation reports first quarter fiscal 2021 financial results.

7 months ago - Business Wire

Should You Buy These 3 Hot Reddit Stocks Before It's Too Late?

Investors are betting that these three stocks could turn them into millionaires in incredibly short periods of time. Will they succeed?

Other symbols:AMCBB
7 months ago - The Motley Fool

CVM Stock: Why Cancer Play Cel-Sci Is Riding the Reddit Wave

CVM stock is on the move after Cel-Sci CEO Geert Kersten joined the battle against GME stock short-sellers. Here's what to know.

7 months ago - InvestorPlace

CEL-SCI Corporation to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference

8 months ago - Business Wire

CEL-SCI Corporation Issues Letter to Shareholders

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation issues letter to shareholders.

8 months ago - Business Wire